论文部分内容阅读
目的:对经皮给药在小儿支原体肺炎中的治疗效果进行讨论。方法:选取我院2013年2月-2014年2月间56例支原体肺炎的小儿,将患者分为两组,1组患者进行常规治疗,2组同时采取经皮给药方式进行治疗,对两组患者的治疗效果进行比较。结果:1组患者治疗后痊愈的有9例,占比例的32.1%,治疗效果显著的为12例,占比例的42.9%,治疗有效的为5例,占比例的17.9%,治疗无效的患者为2例,占比例的7.1%。2组患者治疗后痊愈的为19例,占比例的67.9%,知道效果显著的为8例,占比例的28.6%治疗有效的为1例,占比例的3.5%,无治疗无效的患者,p<0.05认为差异具有统计学意义。1组患者治疗平均时间为13±2.2天,2组患者的平均治疗时间为8±1.3天。结论:经皮给药治疗效果较好,能够有效的提升小儿的治疗效果。
Objective: To discuss the therapeutic effect of transdermal administration in children with mycoplasma pneumonia. Methods: 56 children with mycoplasma pneumonia were selected from February 2013 to February 2014 in our hospital. The patients were divided into two groups. One group received routine treatment. Two groups were treated by transdermal delivery. The treatment effect of the group of patients were compared. Results: One group of patients recovered after treatment, 9 cases, accounting for 32.1% of the proportion, the treatment effect was significantly 12 cases, accounting for 42.9%, effective treatment for 5 cases, accounting for 17.9% of the proportion of patients with ineffective treatment 2 cases, accounting for 7.1% of the proportion. Two groups of patients recovered after treatment for 19 cases, accounting for 67.9% of the total, known to have a significant effect in 8 cases, accounting for 28.6% of the effective treatment was 1 cases, accounting for 3.5% of the total, no treatment ineffective patients, p <0.05 considered the difference as statistically significant. The average duration of treatment in group 1 was 13 ± 2.2 days and in group 2 was 8 ± 1.3 days. Conclusion: Transdermal drug treatment is better, which can effectively improve the therapeutic effect in children.